Home MarketFortis Healthcare Ltd.

Fortis Healthcare Ltd. Stock Info: As on 2017-09-20 15:58:34

Nse

153.55

0.00(0.00%)
Change%
52 Week Range
125.55
22.00
228.95
3.00
Open154.30
Day's Range138.20 - 168.91
Value Traded (in ₹ Cr.) 31.98

Bse

153.50

-0.25(-0.16%)
Change %
52 Week Range
125.65
22.00
230.90
3.00
Open152.00
Day's Range138.38 - 169.13
Value Traded (in ₹ Cr.) 4.81

Stock Exchange

Category No. Of Shares Share %
ForeignPromoters 0.00 0.00%
IndianPromoters 222,762,120.00 42.96%
Mutual Funds/UTI 29,200,572.00 5.63%
FII 169,300,449.00 32.65%
Employee 0.00 0.00%
Public 57,897,660.00 11.17%
Government 0.00 0.00%
Others 37,600,558.00 7.25%
More

Key Statistics

Valuation Measures
Market Cap / Sales Ratio 13.29
Basic EPS (Rs.) -1.59
Cash EPS -1.04
BVPerShare Excl 77.91
Operating Revenue 13.21
PBDITPerShare 0.63
Dividend 0.00
NPPerShare -1.59
Current Ratio 1.85
Quick Ratio 1.84
PriceToBV 2.25
Earnings -0.01
PBDIT Margin 4.80
PBT Margin -12.01
NP Margin -12.01
Return On Assets -1.49
Retention Ratios 0.00
Parameter Mar-16 (₹ Cr.) Yoy%change
Total Income 758.83
Total Expenses 817.00
EBITDA 29.39
PBT -73.51
PAT -73.51
Net Income -73.51
More
Parameter Mar-16 (₹ Cr.) 6M % change
Total Income 376.34
Total Expenses 367.99
EBITDA -5.60
PBT -30.78
PAT -30.78
Net Income 0.00
More
Total Assets
Total Assets
Parameter Mar-16 (₹ Cr.) Yoy%change
Total share capital 463.13
Net worth 3,608.27
Investments 2,635.50
Total Liability 4,909.37
Total debt 1,044.54
Net block 349.23
Total Assets 4,909.37
Parameter Mar-16 (₹ Cr.) 6M % change
Total share capital 463.13
Net worth 3,608.27
Investments 2,635.50
Total Liability 4,909.37
Total debt 1,044.54
Net block 349.23
Total Assets 4,909.37
Company Curr Price Prev. Close Change% W's Low/High

Apollo Hospitals Enterprise Ltd.

1066.4 1057.35 0.86
10481076

Dr. Lal Pathlabs Ltd.

802.15 801.55 0.07
800815.5

Healthcare Global Enterprises Ltd.

267.45 263.95 1.33
255272

Indraprastha Medical Corporation Ltd.

52.7 52.7 0
52.554.15

Kovai Medical Center and Hospital Ltd.

641.65 624.85 2.68
629.9649.9

Lotus Eye Hospital and Institute Ltd.

29.95 30.95 -3.23
28.5534.9

Marico Kaya Enterprises Ltd.

1547.05 1582.55 -2.24
1535.051589
Company Curr Price Prev. Close Change% W's Low/High

ADS Diagnostic Ltd.

11.34 10.8 0
11.3411.34

Apollo Hospitals Enterprise Ltd.

1064 1057.5 0.61
10501074.9

Birla Pacific Medspa Ltd.

0.28 0.27 0
0.270.28

CDR Health Care Ltd.

7.58 2.6 0
7.227.58

Chennai Meenakshi Multispeciality Hospital Ltd.

12.1 12.7 -4.72
12.112.7

Dhanvantri Jeevan Rekha Ltd.

33.25 35 -5
3337

Dolphin Medical Services Ltd.

1.23 1.21 1.65
1.111.25
More
Parameter Mar-16(in ₹ Cr.)
Cash from operating activities -693.61
Cash from investing activities 379.12
Cash from financing activities 317.58
Net change in cash 3.09

Stock Held By Mutual Fund Schemes

Scheme Holding (%)
Aditya Birla Sun Life Balanced 95 Fund 0.51%
ICICI Prudential MidCap Fund 3.69%
ICICI Prudential Equity - Arbitrage Fund 0.38%
Kotak Equity Savings Fund - Regular Plan 4.07%
Aditya Birla Sun Life Pure Value Fund 2.12%
JM Arbitrage Advantage Fund 1.22%

NBCC to launch 1,000 flats for sale during festival

State-owned construction firm NBCC will launch about 1,000 flats for sale in this festival season and is in discussion with the government to develop affordable housing projects on surplus land with PSUs. The company is also in talks with the government for developing islands in Andaman and Nicobar and Lakshadweep, its Chairman and Managing Director Anoop Kumar Mittal said. We have been appointed as land management agency for the surplus land with sick PSUs. We are in close discussion with the government to develop affordable housing projects on some of the land parcels, he told reporters. On developing island, Mittal said the company has experience in developing islands in Maldives and expects to bag similar projects in India. We will be launching 1,000 flats as well as commercial area across the country including Delhi-NCR in this festival. The flats will be in the price range of Rs 15 lakh to Rs 1 crore, he said. Asked about taking over stressed projects of Jaypee Infratech and Amrapali, he said the company has not received any offer from any stakeholder including buyers, builders or the government. However, he said the company would certainly consider if there is any opportunity, provided projects should be viable and not bring bad name to the NBCC. On land purchase from Air India, Mittal said the company had signed an MoU with Air India for monetisation of surplus land assets of the national carrier, but there has not been much progress. However, the CMD said that the company has recently bought a land parcel from Air India in Mauritius for Rs 3 crore. Two years back, it had bought another land parcel from Air India in Coimbatore for Rs 25 crore. Mittal said two land parcels in Vasant Vihar and Baba Kharag Singh Marg in Delhi were given on lease to Air India by the government and the same is being returned to the Ministry of Housing and Urban Affairs. The company could develop projects on these two land parcels, he added. Mittal said the company has an order book of Rs 75,000 crore and the same is likely to touch Rs 1 lakh crore in the next few months. The company has an order book of Rs 700 crore from overseas. On developing railway stations, he said the company has bagged 10 projects and would like to develop at least 4-5 projects before acquiring more such projects from the Railway Ministry. Among major projects, NBCC has bagged over Rs 2,000 crore project to develop integrated exhibition-cum-convention centre for ITPO at Pragati Maidan. NBCC, which is under the administrative control of Ministry of Housing and Urban Affairs, is present in three main segments - Project Management Consultancy (PMC), Real Estate Development and EPC Contracting.

20-09-2017 17:10

NTPC wins Bhubaneswar round of Tata Crucible Corporate Quiz

National Thermal Power Corporation Ltd has emerged the winner of the Bhubaneswar regional round of Tata Crucible Corporate Quiz, 2017. Around 50 teams from prominent corporate houses across the state capital participated in the quiz, which will traverse 25 cities in India, a Tata Group release said. Chandan Shahi and Sujit Varkey of NTPC will compete with winning teams from five cities in the zonal finals. Soubhagya Jena and Gursheel Singh Sahni from Reckitt Benckiser were declared as the runners-up. Suresh G Menon, vice-president and general manager - Tata Consultancy Services Ltd (Eastern Region), yesterday felicitated the winners, who were awarded Rs 75,000, while the runners-up took home a prize money of Rs 35,000. The Tata Crucible Corporate Quiz, 2017 format is based on the concept of 'Real-Time Strategy', involving different rounds, with decision-making and strategy being the key to win the title, the release said. The national winners will get a prize money of Rs 5 lakh, along with the Tata Crucible Trophy, it added.

20-09-2017 15:31

Unichem Lab gets USFDA nod for Ibesartan, Hydrochlorothiazide Tablets

Drug major Unichem Laboratories on Wednesday said it has received ANDA approval from the USFDA for Ibesartan and Hydrochlorothiazide Tablets USP, 150mg/12.5mg and 300 mg/12.5 mg which are therapeutically equivalent to Avalide tablets 150 mg/12.5 mg and 300mg/12.5 mg of Sanofi – Aventis US LLC. “Ibesartan and Hydrochlorothiazide is a combination of Ibesartan, an angiotensin II receptor antagonist and Hydrochlorothiazide, a thiazide diuretic. The product is indicated for hypertension in patients likely to need multiple drugs to achieve their blood pressure goals,” said Unichem Laboratories in a filing to the Bombay Stock Exchange. The product will be commercialised from Unichem’s Ghaziabad plant. API will also be made at Pithampura/Roha API plants, it added. Meanwhile, shares of company were trading at Rs 245 apiece, down 1.33 per cent, from previous close on the BSE at 15:20 hours.

20-09-2017 15:12

GIPCL bags 75 MW solar power projects from GUVNL

Gujarat Industries Power Company (GIPCL) said that it has emerged as one of the successful Bidders for the 75 MW Solar Power Project in the e-reverse auction conducted by Gujarat Urja Vikas Nigam (GUVNL). “GIPCL has emerged as one of the successful Bidders for the 75 MW Solar Power Project in the e-reverse auction conducted by Gujarat Urja Vikas Nigam (GUVNL) on September 19, 2017 for 500 MW Solar Power Projects, in the State of Gujarat. on September 19, 2017 for 500 MW Solar Power Projects, in the State of Gujarat,” the company said in a filing to the Bombay Stock Exchange. GIPCL is engaged in business of Electrical Power Generation. The company has a vision to transform itself into a national level power sector enterprise. Meanwhile, shares of the company were trading at Rs 142.65 apiece, up 2.55 per cent from the previous close at 14:25 hours on BSE.

20-09-2017 14:22

PGCIL board approves Rs 198.50 cr for Baharampur unit

State-run electric utilities company Power Grid Corporation of India on Wednesday said its board has approved investment worth Rs 198.49 crore for Baharampur (POWERGRID) –Bheramara, Bangladesh. “The POWERGRID boards of directors in their meeting on September 19, 2017, have accorded investment approval for Baharampur (POWERGRID) –Bheramara, Bangladesh 2nd 400kV D/c Transmission Line (Indian Portion) at an estimated cost of Rs 198.49 crore,” Power Grid Corporation of India said in a filing to the Bombay Stock Exchange. The company further said that the commissioning schedule for plant is 24 months from the date of investment approval. Meanwhile, shares of company were trading at Rs 213.6 apiece, down 0.81 per cent, from previous close on the BSE at 14:10 hours.

20-09-2017 13:59

Fortis Healthcare - Updates

Fortis Healthcare Limited has informed the Exchange regarding ''''.

15-Sep-2017 10:46 AM

Fortis Healthcare - Updates

This is with reference to the recent news item which appeared in Newspaper - The Economic Times dated September 14, 2017, captioned Religare's Institutional Shareholders move court seeking ouster of Board'.
In this regard, Religare Enterprises Limited ('REL') has given intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, a copy of which is attached for your reference.
Further, we would like to submit that the Company and REL have common Directors and Promoters (directors being Mr. Malvinder Mohan Singh, Dr. Shivinder Mohan Singh and Mr. Harpal Singh).
We confirm that the Company is not a party to the litigation and as such is not involved or impacted by its outcome. Also, any outcome of the proceeding is reasonably expected to have no direct or indirect impact on the Company or its operations.

15-Sep-2017 10:32 AM

Fortis Healthcare - Updates

Fortis Healthcare Limited has informed the Exchange regarding ''Update under Regulation 30''.This is in continuation to our letter dated August 11, 2017, in the matter relating to M/s Daiichi Sankyo Company Limited v/s Oscar Investments Limited & Others, the Hon ble Supreme Court of India today clarified that the directions relating to maintaining status quo with regards to the holding of Fortis Healthcare Holding Private Limited (FHHPL), a Promoter Group Entity, in the Company applies to both the encumbered and unencumbered shares.This is for your kind information and records purposes.

31-Aug-2017 09:50 PM

Fortis Healthcare - Updates

Fortis Healthcare Limited has informed the Exchange regarding ''Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company has today sold off its entire stake in M/s. Fortis Medicare International Limited, an associate company to M/s. Fortis Global Healthcare Private Limited, a promoter group company. The detailed disclosure as required under Regulation 30 is attached herewith.This is for your kind information and records purposes.''.

30-Aug-2017 05:44 PM

Fortis Healthcare - Updates

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company has today sold off its entire stake in M/s. Fortis Medicare International Limited, an associate company to M/s. Fortis Global Healthcare Private Limited, a promoter group company.



The detailed disclosure as required under Regulation 30 is attached herewith.


This is for your kind information and records purposes.

30-Aug-2017 05:36 PM

Fortis Healthcare - Updates

This is with reference to the recent news item which appeared in Newspaper - The Economic Times dated September 14, 2017, captioned Religare's Institutional Shareholders move court seeking ouster of Board'.
In this regard, Religare Enterprises Limited ('REL') has given intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, a copy of which is attached for your reference.
Further, we would like to submit that the Company and REL have common Directors and Promoters (directors being Mr. Malvinder Mohan Singh, Dr. Shivinder Mohan Singh and Mr. Harpal Singh).
We confirm that the Company is not a party to the litigation and as such is not involved or impacted by its outcome. Also, any outcome of the proceeding is reasonably expected to have no direct or indirect impact on the Company or its operations.

15-Sep-2017 10:32 AM

Fortis Healthcare - Updates

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company has today sold off its entire stake in M/s. Fortis Medicare International Limited, an associate company to M/s. Fortis Global Healthcare Private Limited, a promoter group company.



The detailed disclosure as required under Regulation 30 is attached herewith.


This is for your kind information and records purposes.

30-Aug-2017 05:36 PM

Fortis Healthcare - Notice Of 21St Annual General Meeting.


Dear Sirs,

Pursuant to the provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the notice for convening 21st Annual General Meeting of Fortis Healthcare Limited, scheduled to be held on Tuesday, September 26, 2017 at 1200 Noon at National Institute of Pharmaceutical Education and Research Mohali, Sector 67, SAS Nagar, Mohali.

This is for your information and records please.

30-Aug-2017 02:45 PM

Corporate Details

About Management

The registered office of the Company was initially situated at 25, Nehru Place, New Delhi 110 019, India. Pursuant to a Board resolution dated September 16, 2003 the registered office was shifted to B- 9, Maharani Bagh, New Delhi 110 065, India. Subsequently, pursuant to Board resolution dated February 10, 2006 the registered office of the Company was shifted to Piccadily House, 275- 276, 4th Floor, Captain Gaur Marg, Srinivas Puri, New Delhi 110 065, India, which is the current Registered Office. Scheme of merger/amalgamation between Fortis Medical Centre Holdings Limited and the Company dated October 7, 2005: The High Court of Delhi, through its order dated October 7, 2005 in respect of the company petition (C.P. No: 240/2005 and 241/2005) approved the scheme of amalgamation/merger between the Company and Fortis Medical Centre Holdings Limited ("FMCHL"), and which at the time of amalgamation was our board controlled subsidiary, with effect from April 1, 2004 ("Scheme"). Salient features of the Scheme: The principal terms of the Scheme, as sanctioned by the High Court of Delhi, are set forth below: The entire undertaking and business, all properties, tangible and intangible assets including trademarks, patents, design, copyrights, investments, approvals, licenses, tax benefits, pending projects, debts, liabilities and obligations, including income tax liabilities accrued or to accrue in FMCHL was transferred to the Company with effect from April 1, 2004. Pursuant to the Scheme, Fortis Hospital, Amritsar was transferred to the Company. However, the transfer of the aforesaid was subject to the existing charges or hypothecation in respect of the assets of FMCHL. All the staff, workmen and employees of FMCHL in employment on the date immediately preceding December 23, 2005 (i.e., the date on which a certified copy of the order of the High Court of Delhi was filed with the RoC) became the employees of the Company without any break or discontinuity in service and on conditions not less favourable than those subsisting at FMCHL. In consideration of the transfer and vesting of the undertaking and the assets and liabilities of FMCHL and in consideration of the mutual covenants agreed to in the Scheme, the Company agreed to allot the Equity Shares to the existing shareholders of FMCHL, in the ratio of 1:4 (i.e., one Equity Share in exchange of every four equity shares of FMCHL of Rs. 10 each). In compliance with the Scheme, the Company allotted 520,000 Equity Shares to the shareholders of erstwhile FMCHL on February 10, 2006. Major Events: Year Event June 2001 Commissioning of Fortis Hospital, Mohali. August 2003 Inauguration and commissioning of Fortis Hospital, Amritsar. October 2003 Executed an agreement with Seth Jessa Ram and Bros Charitable Hospital Trust for the operation and management of Jessa Ram Hospital, New Delhi. August 200 Commissioning of Fortis Hospital, Noida. September 2005 Acquired 90% of the equity share capital of Escorts Heart Institute and Research Centre Limited resulting in the acquisition of EHCL, EHSSIL, EHSSHL and EHRCL. October 2005 Signed an agreement with Jeewan Mala Hospital Private Limited for the operation and maintenance of Jeewan Mala Hospital, New Delhi. January 2006 Signed an agreement with Sunrise Medicare Private Limited for the operation and management of Fortis La Femme, New Delhi, and acquisition of 5% equity interest in Sunrise Medicare Private Limited, with an option to acquire additional equity shares. January 2006 Signed an agreement with Khalil Public Welfare Trust for the operation and maintenance of Khyber Medical Institute, Srinagar. March 2006 Acquired 99.99% of the paid up equity share capital of International Hospital Limited resulting in the acquisition of Fortis Hospital, Noida. March 2006 Acquired 100.00% of the paid up equity share capital of Oscar Bio-Tech Private Limited. 2004 -Fortis inks deal with Jessa Ram Hospital to takeover the management of the hospital 2005 -Fortis Hospital rolls out Golden Age Club -Fortis buys Escorts Heart -Fortis Healthcare signs $33.33m pre-IPO deals The Company was incorporated on February 28, 1996 as Rancare Limited under the Companies Act. Subsequently on June 20, 1996 our name was changed to our present name-Fortis Healthcare Limited. The Company received the certificate of commencement of business on July 1, 1996. 2006 -Fortis Healthcare to buy majority stake in Trehan`s Medicity -Fortis Healthcare signs $33.33m pre-IPO deals 2007 -Fortis HealthWorld has joined hands with US hearing aid maker Starkey for its Audible range and is looking to soon offer dental services at its Health stores too. -Colgate-Palmolive India, the market leader in toothpaste in India, declared the acquisition of three domestic companies in south India recently. The company purchased 75 per cent equity in Advanced Oral Care Products (Goa), Professional Oral Care Products (Goa) and SS Oral Hygiene Products (Hyderabad). -Fortis Healthcare acquires Hiranandani Hospital 2008 -Fortis Healthcare Ltd has informed that the Board of Directors of the Company at its meeting held on January 23, 2008, inter alia, has approved change in registered office of the Company from "Piccadily House, 275-276, 4th Floor, Captain Gaur Marg, Srinivas Puri, New Delhi - 110065" to "Escorts Health Institute And Research Centre, Okhla Road, New Delhi - 110025". 2009 -Fortis completes Wockhardt Hospital Acquisition -Fortis signs $15 mn outsourcing deal with HCL -Fortis Healthcare Ltd Issues Rights in the Ratio of 2:5 2010 - 25% stake in Parkway holdings, Asia's largest private healthcare provider. - "Fortis Healthcare infuses USD 100 Million". - Fortis increases stake in Parkway. - Government of Singapore Investment Corp (GIC) to join hands with Fortis at strategic level. - Fortis Healthcare has entered into a pact with two hospitals in Dubai and Tanzania to set up specialised medical facilities. - Company has announced its foray into Speciality Medical Centres focused on the management of diabetes, metabolic diseases and endocrinology. 2011 - A Memorandum of Understanding has been signed by Fortis Healthcare Ltd with the University of Utah to develop courses for Emergency Medical Technicians. - Through its wholly owned subsidiary, has entered into an agreement with Cauvery Hospital Limited, Mysore, wherein Fortis will set up, operate and manage a Cardiac Centre in the hospital. - The name of Fortis Healthcare Limited shall be changed to Fortis Healthcare (India) Limited w.e.f. April 11, 2011. - "Fortis Healthcare ties up with TotipotentRX to set up Stem Cell Therapy Centres". - Fortis Healthcare (India) Ltd has announced that it will buy 86 per cent stake in Super Religare Laboratories Ltd (SRL) . - Fortis Healt - Fortis announces new hospitals in Hyderabad and Agra. 2012 - "Fortis to get Rs. 3700 Mn Equity infusion in SRL through IFC and NYLIM Jacob Ballas India". - Fortis Healthcare raises around S$510 mn through Singapore IPO. -Company has changed its name from Fortis Healthcare (India) Ltd. to Fortis Healthcare Ltd. 2013 -"Fortis launches its Flagship Hospital, One of the First of its Kind in Asia Bridges the gap for expert talent, trans-disciplinary, quaternary care". -"Fortis to divest stake in Quality Healthcare to Bupa for US$ 355 million Intensifies Focus on Healthcare Delivery in India". 2014 -"Fortis launches state of the art, multi super-specialty hospital in Ludhiana". 2016 -Fortis Healthcare has fully acquired Religare Health Trust Trustee Manager for USD 14.9 million (about Rs 100 crore). -Fortis group gets CCI nod for internal reorganisation. -Fortis Healthcare First in India to Monitor and Publish Clinical Outcomes for Cardiology. -Fortis Healthcare launches National helpline for students and parents to help deal exam stress.

Registered Office

Fortis-Escorts Hospital: 2nd Floor, Coronation Hospital, Curzon Road,

,,,      ,

Registrar Details

Karvy Computershare Private Ltd.